SAB Biotherapeutics (SABS) Enterprise Value: 147.97M

SAB Biotherapeutics, Inc. (SABS)

2.95 +0.01 (+0.34%) USD | NASDAQ | Nov 06, 10:20

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
November 05, 2026	147.97M
November 04, 2026	168.01M
November 03, 2026	163.00M
November 02, 2026	178.03M
October 30, 2026	182.20M
October 29, 2026	172.18M
October 28, 2026	169.68M
October 27, 2026	158.82M
October 26, 2026	135.45M
October 23, 2026	139.62M
October 22, 2026	156.32M
October 21, 2026	137.95M
October 20, 2026	142.96M
October 19, 2026	119.58M
October 16, 2026	113.74M
October 15, 2026	118.75M
October 14, 2026	110.40M
October 13, 2026	126.26M
October 12, 2026	138.79M
October 09, 2026	151.31M
October 08, 2026	143.80M
October 07, 2026	142.96M
October 06, 2026	147.13M
October 05, 2026	161.33M
October 02, 2026	151.31M

Date	Value
October 01, 2026	157.99M
September 30, 2026	167.17M
September 29, 2026	171.35M
September 28, 2026	170.93M
September 25, 2026	177.19M
September 24, 2026	182.20M
September 23, 2026	185.54M
September 22, 2026	194.73M
September 21, 2026	185.54M
September 18, 2026	195.56M
September 17, 2026	194.73M
September 16, 2026	185.54M
September 15, 2026	187.21M
September 14, 2026	191.39M
September 11, 2026	187.21M
September 10, 2026	188.05M
September 09, 2026	193.06M
September 08, 2026	205.58M
September 04, 2026	213.09M
September 03, 2026	213.09M
September 02, 2026	215.60M
September 01, 2026	211.42M
August 31, 2026	212.26M
August 28, 2026	218.94M
August 27, 2026	230.63M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks